


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.17%
+6.81%
+2.00%
-7.29%
-26.16%
INSM
Insmed
$199.66
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Investors confidence is positive
Chart
$165.31 (+20.78%)
$128.32 (+55.60%)
$99.49 (+100.68%)
$72.42 (+175.70%)
INSM has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

INSM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
INSM Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
INSM Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displaySNY
49.10
-0.89%
XOMA
32.18
-2.93%
REGN
740.88
+5.54%
MRK
94.92
-0.19%
MLTX
13.23
-2.29%
What is INSM current stock price?
What are INSM stock strengths?
What is INSM Risk Level?
What is INSM market cap and volume?
What is INSM current Stock IQ?
Should I buy INSM stock right now?
Is INSM a Strong Buy right now?
What does a 'Strong Buy' rating mean for INSM?
What does a 'Strong Sell' rating mean for INSM?
What factors influence INSM's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.17%
+6.81%
+2.00%
-7.29%
-26.16%
INSM
Insmed
Current Price
$199.66
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Investors confidence is positive
Linked to INSM
SNY
49.10
-0.89%
XOMA
32.18
-2.93%
REGN
740.88
+5.54%
MRK
94.92
-0.19%
MLTX
13.23
-2.29%

Chart
$165.31 (+20.78%)
$128.32 (+55.60%)
$99.49 (+100.68%)
$72.42 (+175.70%)
INSM Analysts Opinion
INSM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Earnings decline YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
INSM Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
INSM Street Sentiment is extremely bullish and have positive views on the near-term outlook
INSM has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
INSM Latest Analysis
Insmed Stock Rise on EU Nod for Lung Disease Drug Brinsupri. INSM climbs after the EU clears Brinsupri as the first approved treatment for NCFB backed by phase III ASPEN and phase II WILLOW results.
Wed Nov 19, 2025
Insmeds BRINSUPRI Wins EU Approval Expanding Global Reach After United States Nod . (RTTNews) - Insmed Incorporated (INSM) announced that the European Commission has approved BRINSUPRI for the treatment of non-cystic fibrosis bronchiectasis in patients aged 12 and older with recurrent exacerbations.
Wed Nov 19, 2025
From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? . (RTTNews) - The biotech sector continues to deliver headline-grabbing moves with stocks surging to fresh highs and companies advancing pivotal trials regulatory filings and strategic offerings. For investors the pace of innovation and volatility underscores Warren Buffetts t
Wed Nov 19, 2025
Insmed director Anderson sells $1.96 million in stock.
Tue Nov 18, 2025
Insmed Incorporated (INSM) Presents at Jefferies London Healthcare Conference 2025 Transcript.
Tue Nov 18, 2025
Insmed (INSM) Price Target Increased by 15.76% to 206.22. The average one-year price target for Insmed (NasdaqGS:INSM) has been revised to $206.22 / share. This is an increase of 15.76% from the prior estimate of $178.15 dated November 7 2025. The price target is an average of many targets provided by analysts. The
Mon Nov 17, 2025
Approval of Brinsupri Lifted Insmed Incorporated (INSM) in Q3.
Mon Nov 3, 2025
Heres How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today. Insmed (NASDAQ:INSM) has outperformed the market over the past 10 years by 12.7% on an annualized basis producing an average annual return of 25.23%. Currently Insmed has a market capitalization of $41.43 billion.
Fri Oct 31, 2025
Insmed Misses on Q3 Earnings Stock Rises on Strong Brinsupri Uptake. INSM shares jump 16% as Brinsupris strong debut offset wider Q3 losses lifting revenue 52% year over year.
Fri Oct 31, 2025
Insmed (INSM) Hits All-Time High as Firm Posts Highly Optimistic Outlook. We recently published 10 Stocks with Outstanding Gains. 9 on Record Highs. Insmed Inc. (NASDAQ:INSM) is one of the best-performing stocks on Thursday. Insmed rallied for a fourth straight day to reach a new all-time high as investors took heart from a highly optimistic business outlook for the full-year period despite widening its net loss [….]
Fri Oct 31, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
INSM Stock trends
INSM Stock performance
INSM Stock analysis
INSM investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.